XML 99 R86.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information (Schedule of Business Segments) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Segment Reporting Information [Line Items]          
Net sales $ 1,411 $ 1,586 $ 4,064 $ 4,865  
Other (charges) gains, net (Note 14) (10) (7) (37) (101)  
Operating profit (loss) 184 260 461 766  
Equity in net earnings (loss) of affiliates 25 45 113 134  
Depreciation and amortization 89 94 261 261  
Capital expenditures 76 [1] 87 [1] 242 [2] 215 [2]  
Goodwill and intangible assets, net 1,445   1,445   $ 1,386
Total assets 9,769   9,769   9,476
Increase (decrease) in accrued capital expenditures 4 5 (37) (11)  
Acetate Tow          
Segment Reporting Information [Line Items]          
Net sales 129 158 385 488  
Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales [3] 756 837 2,170 2,530  
Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 526 591 1,509 1,847  
Operating Segments [Member] | Acetate Tow          
Segment Reporting Information [Line Items]          
Net sales 129 158 385 488  
Other (charges) gains, net (Note 14) 0 (3) (1) (87)  
Operating profit (loss) 30 34 88 30  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Depreciation and amortization 9 14 26 35  
Capital expenditures 10 9 26 28  
Goodwill and intangible assets, net 153   153   153
Total assets 944   944   977
Operating Segments [Member] | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales 776 867 2,237 2,621  
Other (charges) gains, net (Note 14) 1 0 6 (1)  
Operating profit (loss) 121 180 377 570  
Equity in net earnings (loss) of affiliates 2 1 3 3  
Depreciation and amortization 41 43 122 119  
Capital expenditures 37 47 118 108  
Goodwill and intangible assets, net 286   286   234
Total assets 3,755   3,755   3,489
Operating Segments [Member] | Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 526 591 1,509 1,847  
Other (charges) gains, net (Note 14) (10) (1) (35) 6  
Operating profit (loss) 84 111 173 358  
Equity in net earnings (loss) of affiliates 21 41 100 123  
Depreciation and amortization 34 33 100 96  
Capital expenditures 21 23 73 60  
Goodwill and intangible assets, net 1,006   1,006   999
Total assets 4,069   4,069   4,125
Corporate, Non-Segment [Member] | Other          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 0  
Other (charges) gains, net (Note 14) (1) (3) (7) (19)  
Operating profit (loss) (51) (65) (177) (192)  
Equity in net earnings (loss) of affiliates 2 3 10 8  
Depreciation and amortization 5 4 13 11  
Capital expenditures 8 8 25 19  
Goodwill and intangible assets, net 0   0   0
Total assets 1,001   1,001   885
Eliminations [Member]          
Segment Reporting Information [Line Items]          
Net sales (20) [4] (30) [4] (67) [5] (91) [5]  
Other (charges) gains, net (Note 14) 0 0 0 0  
Operating profit (loss) 0 0 0 0  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Depreciation and amortization 0 0 0 0  
Capital expenditures 0 0 0 0  
Goodwill and intangible assets, net 0   0   0
Total assets 0   0   $ 0
Eliminations [Member] | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales $ 20 $ 30 $ 67 $ 91  
[1] Includes an increase in accrued capital expenditures of $4 million and $5 million for the three months ended September 30, 2020 and 2019, respectively.
[2] Includes a decrease in accrued capital expenditures of $37 million and $11 million for the nine months ended September 30, 2020 and 2019, respectively.
[3] Excludes intersegment sales of $20 million and $30 million for the three months ended September 30, 2020 and 2019, respectively. Excludes intersegment sales of $67 million and $91 million for the nine months ended September 30, 2020 and 2019, respectively.
[4] Includes intersegment sales primarily related to the Acetyl Chain.
[5] Includes intersegment sales primarily related to the Acetyl Chain.